GIKLY
Price
$7.49
Change
+$0.45 (+6.39%)
Updated
Jul 31 closing price
Capitalization
8.92B
82 days until earnings call
OPHLY
Price
$3.86
Change
-$0.02 (-0.52%)
Updated
Aug 15 closing price
Capitalization
5.45B
75 days until earnings call
Interact to see
Advertisement

GIKLY vs OPHLY

Header iconGIKLY vs OPHLY Comparison
Open Charts GIKLY vs OPHLYBanner chart's image
Grifols Sa
Price$7.49
Change+$0.45 (+6.39%)
Volume$100
Capitalization8.92B
Ono Pharmaceutical
Price$3.86
Change-$0.02 (-0.52%)
Volume$174.07K
Capitalization5.45B
GIKLY vs OPHLY Comparison Chart in %
Loading...
GIKLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OPHLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GIKLY vs. OPHLY commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GIKLY is a Buy and OPHLY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (GIKLY: $7.49 vs. OPHLY: $3.86)
Brand notoriety: GIKLY and OPHLY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: GIKLY: 9% vs. OPHLY: 55%
Market capitalization -- GIKLY: $8.92B vs. OPHLY: $5.45B
GIKLY [@Pharmaceuticals: Major] is valued at $8.92B. OPHLY’s [@Pharmaceuticals: Major] market capitalization is $5.45B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $628.62B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $87.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GIKLY’s FA Score shows that 1 FA rating(s) are green whileOPHLY’s FA Score has 3 green FA rating(s).

  • GIKLY’s FA Score: 1 green, 4 red.
  • OPHLY’s FA Score: 3 green, 2 red.
According to our system of comparison, OPHLY is a better buy in the long-term than GIKLY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GIKLY’s TA Score shows that 2 TA indicator(s) are bullish while OPHLY’s TA Score has 4 bullish TA indicator(s).

  • GIKLY’s TA Score: 2 bullish, 3 bearish.
  • OPHLY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, OPHLY is a better buy in the short-term than GIKLY.

Price Growth

GIKLY (@Pharmaceuticals: Major) experienced а +2.39% price change this week, while OPHLY (@Pharmaceuticals: Major) price change was +0.52% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +2.79%. For the same industry, the average monthly price growth was +6.10%, and the average quarterly price growth was +13.36%.

Reported Earning Dates

GIKLY is expected to report earnings on Nov 06, 2025.

OPHLY is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+2.79% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GIKLY($8.92B) has a higher market cap than OPHLY($5.45B). GIKLY has higher P/E ratio than OPHLY: GIKLY (29.05) vs OPHLY (16.02). GIKLY YTD gains are higher at: 63.059 vs. OPHLY (10.920). OPHLY has higher annual earnings (EBITDA): 141B vs. GIKLY (1.62B). OPHLY has higher revenues than GIKLY: OPHLY (484B) vs GIKLY (7.45B).
GIKLYOPHLYGIKLY / OPHLY
Capitalization8.92B5.45B164%
EBITDA1.62B141B1%
Gain YTD63.05910.920577%
P/E Ratio29.0516.02181%
Revenue7.45B484B2%
Total CashN/A181B-
Total DebtN/A162B-
FUNDAMENTALS RATINGS
GIKLY vs OPHLY: Fundamental Ratings
GIKLY
OPHLY
OUTLOOK RATING
1..100
3510
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
4
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8120
PRICE GROWTH RATING
1..100
3850
P/E GROWTH RATING
1..100
6910
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OPHLY's Valuation (4) in the null industry is in the same range as GIKLY (28). This means that OPHLY’s stock grew similarly to GIKLY’s over the last 12 months.

OPHLY's Profit vs Risk Rating (100) in the null industry is in the same range as GIKLY (100). This means that OPHLY’s stock grew similarly to GIKLY’s over the last 12 months.

OPHLY's SMR Rating (20) in the null industry is somewhat better than the same rating for GIKLY (81). This means that OPHLY’s stock grew somewhat faster than GIKLY’s over the last 12 months.

GIKLY's Price Growth Rating (38) in the null industry is in the same range as OPHLY (50). This means that GIKLY’s stock grew similarly to OPHLY’s over the last 12 months.

OPHLY's P/E Growth Rating (10) in the null industry is somewhat better than the same rating for GIKLY (69). This means that OPHLY’s stock grew somewhat faster than GIKLY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GIKLYOPHLY
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
73%
Momentum
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
54%
MACD
ODDS (%)
Bearish Trend 2 days ago
75%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
52%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 2 days ago
50%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
51%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
64%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
59%
Bearish Trend 2 days ago
74%
Aroon
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
54%
View a ticker or compare two or three
Interact to see
Advertisement
GIKLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OPHLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IHYF22.710.03
+0.13%
Invesco High Yield Bond Factor ETF
GPTY45.71-0.01
-0.03%
YieldMax AI & Tech Portfolio Option Income ETF
QLTA47.88-0.06
-0.13%
iShares Aaa - A Rated Corporate Bond ETF
TMET24.26-0.07
-0.29%
iShares Transition-Enabling Metals ETF
BIBL42.44-0.25
-0.60%
Inspire 100 ETF

GIKLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, GIKLY has been closely correlated with GRFS. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if GIKLY jumps, then GRFS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GIKLY
1D Price
Change %
GIKLY100%
N/A
GRFS - GIKLY
68%
Closely correlated
-0.19%
GIFOF - GIKLY
27%
Poorly correlated
N/A
GIFLF - GIKLY
25%
Poorly correlated
N/A
ORINY - GIKLY
9%
Poorly correlated
N/A
OPHLY - GIKLY
8%
Poorly correlated
-0.52%
More

OPHLY and

Correlation & Price change

A.I.dvisor indicates that over the last year, OPHLY has been loosely correlated with OTSKY. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if OPHLY jumps, then OTSKY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OPHLY
1D Price
Change %
OPHLY100%
-0.52%
OTSKY - OPHLY
42%
Loosely correlated
+0.16%
ALPMY - OPHLY
36%
Loosely correlated
+0.98%
CHGCY - OPHLY
26%
Poorly correlated
+2.36%
BAYRY - OPHLY
22%
Poorly correlated
+2.33%
OPHLF - OPHLY
14%
Poorly correlated
N/A
More